IP Library › Granted Patent US 12,630,813
Granted Patent B2
US 12,630,813 · App. 18/429,347 · Granted May 19, 2026

TEV protease with dual affinity tags

Inventors: Dapeng Sun (Lexington, MA); Zhenyu Zhu (Lynnfield, MA); Aine Quimby (Newburyport, MA)
Assignee: ABCLONAL SCIENCE, INC.
C12N9/6472C07K2319/21C12Y304/22044
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,630,813
App. No.
18/429,347
Granted
May 19, 2026
Kind
B2
Abstract

Disclosed is using a TEV protease (wild type or mutant) suited for removal from a reaction mixture, wherein the TEV protease displays a dual affinity tag including a chitin binding domain (CBD) tag and a histidine tag, preferably where the CBD tag precedes the N-terminus of the protease and the CBD tag is preceded by the histidine tag, which is preferably a 6-mer histidine tag; and optionally further including linkers, preferably Gly-Ser linkers, and more preferably a 6-mer Gly-Ser linker, between the tags. A linker, also preferably a Gly-Ser linker, can also follow the CBD tag and precede the protease portion. In certain embodiments, no such linkers are present and in other embodiments, only one such linker is present.

Claims (18)

1 . A process of cleaving a target protein with a fusion protein having sequences of Tobacco Etch Virus protease, wild type or mutant, with two affinity tags, and then removing the fusion protein after cleavage by binding to either or both of the affinity tags, comprising:

generating the fusion protein where a chitin binding domain precedes the residues representing the N-terminus of the protease, and the chitin binding domain is preceded by a poly-histidine tag;

combining the fusion protein with a substrate for cleavage by the fusion protein in a reaction solution under reaction conditions; and

binding the fusion protein to a solid support having chitin on its support surface or wherein the solid support bears a metal.

2 . The process of claim 1 wherein the solid support is a resin or a magnetic bead.

3 . The process of claim 2 wherein the magnetic bead includes nickel.

4 . The process of claim 2 wherein the solid support is a magnetic bead and further including removing the magnetic beads bearing the bound fusion protein from the reaction solution using magnetic attraction.

5 . The process of claim 1 wherein the fusion protein has a series of glycine and serine residues between the poly-histidine tag and the chitin binding domain.

6 . The process of claim 5 further including a series of glycine and serine residues between the chitin binding domain and the residues at the N-terminus of the protease.

7 . The process of claim 6 wherein the linkers are both 6-mers.

8 . The process of claim 6 wherein the linkers are both: GSGSSG (SEQ ID NO: 7).

9 . The process of claim 1 wherein the fusion protein includes a MKI leader sequence.

10 . A process of cleaving a target protein with a fusion protein having the sequence of SEQ ID NO:2 with two affinity tags, and then removing the fusion protein after cleavage by binding to either or both of the affinity tags, comprising:

combining the fusion protein with a substrate for cleavage by the fusion protein in a reaction solution under reaction conditions; and

binding the fusion protein to a solid support having chitin on its support surface or wherein the solid support bears a metal.

11 . The process of claim 10 wherein the solid support is a resin or a magnetic bead.

12 . The process of claim 11 wherein the magnetic bead includes nickel.

13 . The process of claim 11 wherein the solid support is a magnetic bead and further including removing the magnetic beads bearing the bound fusion protein from the reaction solution using magnetic attraction.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2024
From: SUN, DAPENG; QUIMBY, AINE; ZHU, ZHENYU
To: ABCLONAL SCIENCE, INC.
Reel/Frame 068241/0762 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 6, 2024
From: QUIMBY, AINE; ZHU, ZHENYU; SUN, DAPENG
To: ABCLONAL SCIENCE, INC
Reel/Frame 066398/0249 →
Continuity (2)
Provisional Application 63442788 · Feb 2, 2023
Related Publication 20240392276A1 · Nov 28, 2024
References Cited (35)
US 10920202B1 · Zhu et al. · 2021 [cited by applicant]
US 10947518B1 · Zhu et al. · 2021 [cited by applicant]
US 11020474B1 · Xiang et al. · 2021 [cited by applicant]
US 12358947B2 · Stikeleather · 2025 [cited by examiner]
US 20200283825A1 · Zhu et al. · 2020 [cited by applicant]
US 20200291455A1 · Zhu et al. · 2020 [cited by applicant]
US 20200362320A1 · Zhu et al. · 2020 [cited by applicant]
US 20210079365A1 · Zhu et al. · 2021 [cited by applicant]
US 20210087550A1 · Zhu et al. · 2021 [cited by applicant]
US 20210171925A1 · Zhu et al. · 2021 [cited by applicant]
US 20210380655A1 · Grinstaff · 2021 [cited by examiner]
US 20210403537A1 · Xiang et al. · 2021 [cited by applicant]
US 20220064266A1 · Xiang et al. · 2022 [cited by applicant]
US 20220106576A1 · Zhu et al. · 2022 [cited by applicant]
US 20230033390A1 · Xiang · 2023 [cited by applicant]
US 20230094503A1 · Zhu et al. · 2023 [cited by applicant]
US 20230111383A1 · Zhu et al. · 2023 [cited by applicant]
US 20230212550A1 · Zhu et al. · 2023 [cited by applicant]
US 20230257425A1 · Kwon · 2023 [cited by examiner]
US 20230265412A1 · Zhu et al. · 2023 [cited by applicant]
US 20230295707A1 · Zhu et al. · 2023 [cited by applicant]
US 20240052326A1 · Zhu et al. · 2024 [cited by applicant]
US 20240067951A1 · DiCicco et al. · 2024 [cited by applicant]
US 20240124854A1 · Zhu et al. · 2024 [cited by applicant]
US 20240247246A1 · Sun et al. · 2024 [cited by applicant]
US 20240279626A1 · Sun et al. · 2024 [cited by applicant]
US 20240392264A1 · Zhu et al. · 2024 [cited by applicant]
US 20240392267A1 · Zhu et al. · 2024 [cited by applicant]
US 20240392276A1 · Sun et al. · 2024 [cited by applicant]
US 20240392336A1 · Sun et al. · 2024 [cited by applicant]
US 20250051739A1 · Zhu et al. · 2025 [cited by applicant]
US 20250223574A1 · Zhu et al. · 2025 [cited by applicant]
US 20250236860A1 · Sun et al. · 2025 [cited by applicant]
Chung et al., The Use of Inulinase Pre-Pro Leader Peptide for Secretion of Heterologous Proteins in [cited by examiner]
Stamsas et al., CHIC, a new tandem affinity tag for the protein purification toolbox . J. Mocrobiol., Methods., 2013, vol. 92: 59-63 (Year: 2013). [cited by examiner]